Translational Oncology

Article	Citations
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities	1513
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario	131
Hypoxia induced cell dormancy of salivary adenoid cystic carcinoma through miR-922/DEC2 axis	109
Which evaluation criteria of the short-term efficacy can better reflect the long-term outcomes for patients with nasopharyngeal carcinoma?	98
Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer	96
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma	80
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives	77
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma	73
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors	69
Lung cancer and oncolytic virotherapy——enemy's enemy	59
Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors	55
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics	53
circ-ZEB1 regulates epithelial-mesenchymal transition and chemotherapy resistance of colorectal cancer through acting on miR-200c-5p	51
Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study	49
A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells	48
The double face of cold in cancer	45
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells	45
The roles of Linc-ROR in the regulation of cancer stem cells	44
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection	44
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma	42
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition	42
MAGI2-AS3 hypermethylated in promoter region promotes migration and invasion of head and neck squamous cell carcinoma via miRNA-31-5p/AR axis	42
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate	41
AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane	41
Type of chemotherapy has substantial effects on the immune system in ovarian cancer	41

Corrigendum to “Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer” [Transl Oncol. 2024 Aug;46:101983.]	41
Inhibition of hERG by ESEE suppresses the progression of colorectal cancer	40
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma	40
Universal CAR cell therapy: Challenges and expanding applications	40
High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer	38
Prognostic significance of combined PCPE-1 and α-fetoprotein for hepatocellular carcinoma	37
ISO-upregulated BECN1 specifically promotes LC3B-dependent autophagy and anticancer activity in invasive bladder cancer	35
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients	35
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma	34
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer	34
Improving differential diagnosis of pulmonary large cell neuroendocrine carcinoma and small cell lung cancer via a transcriptomic, biological pathway-based machine learning model	34
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors	34
Exposure to Tobacco Smoking Induces a subset of Activated Tumor-resident Tregs in Non-Small Cell Lung Cancer	33
Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma	33
Elacestrant in metastatic breast cancer: Is the “standard of care” meeting standard requirements?	32
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy	32
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation	31
SNF5, a core subunit of SWI/SNF complex, regulates melanoma cancer cell growth, metastasis, and immune escape in response to matrix stiffness	31
Preliminary study on the role of the C5orf46 gene in renal cancer	31
Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells	30
Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis	30
Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later?	30
CBX7 regulates metastasis of basal-like breast cancer through Twist1/EphA2 pathway	29
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways	28
A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?	28
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients	28
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells	27
Ubiquitin-proteasome system reveals clinical subtypes with distinct molecular characteristics and prognoses in gastric cancer	27
G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells	27
Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer	27
Resveratrol induces the growth inhibition of CDX-deficient gastric cancer cells using CDX2 and RUNX3 via the β-catenin/TCF4 signaling pathway	27
Downregulation of miR-221–3p promotes the ferroptosis in gastric cancer cells via upregulation of ATF3 to mediate the transcription inhibition of GPX4 and HRD1	27
Liquid Biopsies: Emerging role and clinical applications in solid tumours	27
Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience	26
Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends	26
Comprehensive analysis of P2Y family genes expression, immune characteristics, and prognosis in pan-cancer	26
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency	26
Multi-Omics Analysis Elucidates The Immune And Intratumor Microbes Characteristics Of Ubiquitination Subtypes In Lung Adenocarcinoma	25
Overexpressed kinetochore genes are used by cancer cells as genome destabilizers and transformation catalysts	25
Clinical identification of malignant pleural effusions	25
Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1	25
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer	24
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma	24
Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture	24
Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer	24
Hsa_circ_0020134 promotes liver metastasis of colorectal cancer through the miR-183-5p-PFN2-TGF-β/Smad axis	24
An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers	23
IGFBP1 promotes the proliferation and migration of lung adenocarcinoma cells through the PPARα pathway	23
Pancreatobiliary reflux increases macrophage-secreted IL-8 and activates the PI3K/NFκB pathway to promote cholangiocarcinoma progression	23
Neoadjuvant followed by adjuvant pembrolizumab in melanoma: time biases in the data analysis of the SWOG S1801 trial.	23

FUBP1 in human cancer: Characteristics, functions, and potential applications	23
Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics	23
Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance	23
ACAT1 suppresses clear cell renal cell carcinoma progression by AMPK mediated fatty acid metabolism	23
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines	22
Transient-resting culture after activation enhances the generation of CD8+ stem cell-like memory T cells from peripheral blood mononuclear cells	22
Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection	22
SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation	22
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma	22
Lp-PLA2, a potential protector of lung cancer patients complicated with pleural effusion from lung diseases, proves effective for the diagnosis and pathological classification of lung cancer	22
Monitoring HOTTIP levels on extracellular vesicles for predicting recurrence in surgical non-small cell lung cancer patients	21
Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation	21
General treatment for metastatic colorectal cancer: From KEYNOTE 177 study	21
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates	21
Long non-coding RNA LINC01215 promotes epithelial-mesenchymal transition and lymph node metastasis in epithelial ovarian cancer through RUNX3 promoter methylation	21
The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epid	21
Split-bolus computed tomography urography (CTU) achieves more than half of radiation dose reduction in females and overweight patients than conventional single-bolus computed tomography urography	20
Peripheral blood values as predictors of autoimmune status in oral cavity squamous cell carcinoma	20
miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway	19
Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study	19
MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B	19
The role of exosomal PD-L1 in tumor immunotherapy	19
Anlotinib exerts potent antileukemic activities in Ph chromosome negative and positive B-cell acute lymphoblastic leukemia via perturbation of PI3K/AKT/mTOR pathway	19
Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma	19
Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score	19
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors	19
Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway	18
Prognostic value of hypoxia-responsive gene expression profile in patients diagnosed with head and neck squamous cell carcinoma	18
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation	18
The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer	18
Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma	18
Sunitinib versus imatinib dose escalation after failure of imatinib standard dose in patients with advanced Gastrointestinal stromal tumors – a real-world multi-center study	18
Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma	18
Investigation of fatty acid metabolism-related genes in breast cancer: Implications for Immunotherapy and clinical significance	18
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome	18
A Novel Scoring Model of Deubiquitination Patterns Predicts Prognosis and Immunotherapeutic Response in Hepatocellular Carcinoma	18
NLRC5 potentiates anti-tumor CD8+ T cells responses by activating interferon-β in endometrial cancer	18
Loss of FAM60A attenuates cell proliferation in glioma via suppression of PI3K/Akt/mTOR signaling pathways	17
Hopes on immunotherapy targeting B7-H3 in neuroblastoma	17
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study	17
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors	17
MTA2 sensitizes gastric cancer cells to PARP inhibition by induction of DNA replication stress	17
KLF4 suppresses the proliferation and metastasis of NSCLC cells via inhibition of MSI2 and regulation of the JAK/STAT3 signaling pathway	17
Incidence and severity of acute radiation induced toxicities among breast cancer patients treated with adjuvant radiotherapy at a major cancer treatment center in Ghana	17
EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia	17
Survival outcome after stereotactic body radiotherapy for locally advanced and borderline resectable pancreatic cancer: A systematic review and meta-analysis	17
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma	17
FGF9/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer	16
CT-based radiomics model with machine learning for predicting primary treatment failure in diffuse large B-cell Lymphoma	16
BRMS1L confers anticancer activity in non-small cell lung cancer by transcriptionally inducing a redox imbalance in the GPX2-ROS pathway	16
Differences in potential key genes and pathways between primary and radiation-associated angiosarcoma of the breast	16
Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways	16
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization	16
Oncolytic vaccinia virus armed with 4–1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancreatic cancer model	16
FERMT1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by activating EGFR/AKT/β-catenin and EGFR/ERK pathways	16
A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1	16
First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trial	16
PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfalls	16
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy	16
SOX4 promotes vascular abnormality in glioblastoma and is a novel target to improve drug delivery	16
Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K/AKT pathway	16
MTA1-TJP1 interaction and its involvement in non-small cell lung cancer metastasis	16
BET inhibitor and CDK4/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair	15
A conventional radiomics model for predicting disease-free survival in colorectal cancer patients with liver metastasis	15
Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage	15
Potentially actionable targets in synovial sarcoma: A tissue microarray study	15
Corrigendum to “ACAT1 suppresses clear cell renal cell carcinoma progression by AMPK mediated fatty acid metabolism” [Transl Oncol 47:102043(Sep 2024) 102043]	15
Corrigendum to “Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells” [Translational Oncology 27 (2023) 1–9/101564]	15
Identification and validation of serum MUC17 as a non‐invasive early warning biomarker for screening of gastric intraepithelial neoplasia	15
PPIC-labeled CAFs: Key players in neoadjuvant chemotherapy resistance for gastric cancer	15
Molecular profiling of head and neck squamous cell carcinomas in North-eastern Italy identifies possible tumour cell vulnerabilities	15
Niraparib perturbs autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma and exhibits anticancer potential against gemcitabine-resistant PDAC	15
Cytochrome P450 F3 promotes colorectal cancer via inhibiting NRF2-mediated ferroptosis	15
The current landscape of the FDA approved companion diagnostics	14
PSMA theragnostics for metastatic castration resistant prostate cancer	14
A monoclonal antibody against annexin A2 targets stem and progenitor cell fractions in tumors	14
Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma	14
Research progress of antibody-drug conjugates therapy for HER2-low expressing gastric cancer	14
Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers	14
OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis	14

Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies	14
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation	14
Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer	14
Radiotherapy: Brightness and darkness in the era of immunotherapy	14
STIL facilitates the development and malignant progression of triple-negative breast cancer through activation of Fanconi anemia pathway via interacting with KLF16	14
A new missense mutation c.1240A>G in fumarate hydratase gene leads to uterine leiomyoma associated hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in Chinese	14
Demethylzeylasteral exerts potent efficacy against non-small-cell lung cancer via the P53 signaling pathway	14
Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia	14
Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learning	14
Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review	14
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways	13
Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells	13
In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review	13
Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients	13
Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer	13
ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma	13
A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer	13
TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway	13
Corrigendum to “PMAIP1-Mediated Glucose Metabolism and its Impact on the Tumor Microenvironment in Breast Cancer: Integration of Multi-Omics Analysis and Experimental Validation” [Translational Oncolo	13
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis	13
The clinical application of 68Ga-PSMA PET/CT and regulating mechanism of PSMA expression in patients with brain metastases of lung cancer	13
Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue	13
KIAA1529 regulates RAD51 expression to confer PARP inhibitors resistance in ovarian cancer	13
Diagnostic assessment of deep learning for melanocytic lesions using whole-slide pathological images	13
Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma	13
Novel antigens of CAR T cell therapy: New roads; old destination	13
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer	13
SPRY1 regulates macrophage M1 polarization in skin aging and melanoma prognosis	13
Synergistic effects of HO-1 inhibition and chemotherapy on tumor proliferation and immune infiltration: An in vitro and in vivo approach to enhancing prostate cancer treatment	13
Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma	13
Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer	13
MIAT: A pivotal oncogenic long noncoding RNA tunning the hallmarks of solid malignancies	13
PTBP3 promotes tumorigenesis of glioblastoma by stabilizing Twist1	13
Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma	13
LncRNA RP1-86C11.7 exacerbates the glioma progression and oncogenicity by hsa-miR-144-3p/TFRC signaling.	13
Comprehensive analysis and experiments identified ANXA1 as an unfavorable prognosticator in glioma	13
The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy	13
Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade	13
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification	12
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells	12
Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma	12
Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing	12
Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers	12
Corrigendum to “Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation” [Translational Oncology 39 (2024) 101824]	12
Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer	12
Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines	12
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review	12
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia	12
Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data	12
Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy	12
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer	12
Insights into molecular mechanisms of chemotherapy resistance in cancer	12
USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression	12
Identification of HSPD1 as a novel invasive biomarker associated with mitophagy in pituitary adenomas	12
Corrigendum to “Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer” [Translational Oncology 44 (2024) 1–10/101923]	12
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer	12
Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation	12
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation	12
Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma	11
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations	11
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma	11
Plasma extracellular vesicles proteomics in meningioma patients	11
Chaihu Shugan San and Zuogui Yin synergistically improve premature ovarian failure in a rat model via the PI3K/Akt/mTOR pathway	11
Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cells	11
Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer	11
SLC2A1 boosts the resistance of non-small cell lung cancer to taxanes by stimulating the formation of EPCAM+ cancer stem-like cells via glycolysis	11
The value of circulating tumor cells with positive centromere probe 8 in the diagnosis of small pulmonary nodules	11
Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer	11
STRN-ALK rearranged pediatric malignant peritoneal mesothelioma – Functional testing of 527 cancer drugs in patient-derived cancer cells	11
Genome-scale CRISPR-Cas9 knockout screening in nasopharyngeal carcinoma for radiosensitive and radioresistant genes	11
Currents status of radiotracers for breast cancer imaging in PET	11
Multi-omic and machine learning analysis of mitochondrial RNA modification genes in lung adenocarcinoma for prognostic and therapeutic implications	11
Healthcare provider perspectives on integrating HIV care into cancer centers in Malawi, South Africa, Uganda, and Zimbabwe	11
Cellular heterogeneity and communication networks in gastric cancer: Single-cell analysis reveals β-hydroxybutyrylation-associated genes and immune infiltration characteristics	11
Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities	11
Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives	11
BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy	11
SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway	11
Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity	11
Single-cell sequencing revealed the necessity of macrophages in brain microenvironment remodeling by breast cancer metastasis	11
Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC	11
Malignant phyllodes tumors with sarcomatous components: A histopathologic and molecular study	11
Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p/EIF5A2 pathway	11
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant	11
High-dose chemotherapy sensitizes locally advanced esophageal squamous cell carcinoma to PD-1 blockade for a higher pathological complete response rate and survival	10
Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model	10
Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma	10
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cyt	10
PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1	10
Long non-coding RNA ZNF667-AS1 retards the development of esophageal squamous cell carcinoma via modulation of microRNA-1290-mediated PRUNE2	10
Commentary: A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria	10
Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods	10
NOTCH pathway inactivation reprograms stem-like oral cancer cells to JAK-STAT dependent state and provides the opportunity of synthetic lethality	10
Therapeutic potential of tLyp-1-EV-shCTCF in inhibiting liver cancer stem cell self-renewal and immune escape via SALL3 modulation in hepatocellular carcinoma	10
DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells	10